U.S. Capital Wealth Advisors’s DexCom DXCM Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Buy	3,657 +449	+14%	+$31.3K	0.01%	903
2025 Q4	$213K	Buy	+3,208	New	+$207K	0.01%	909
2023 Q3	–	Sell	-14,780	Closed	-$1.9M	–	648
2023 Q2	$1.9M	Hold	14,780	–	–	0.09%	218
2023 Q1	$1.72M	Buy	14,780 +3	+0%	+$336	0.08%	228
2022 Q4	$1.67M	Buy	14,777 +49	+0.3%	+$5.38K	0.08%	239
2022 Q3	$1.19M	Hold	14,728	–	–	0.06%	303
2022 Q2	$1.1M	Sell	14,728 -12	-0.1%	-$1.09K	0.05%	333
2022 Q1	$1.89M	Sell	14,740 -1,988	-12%	-$217K	0.07%	265
2021 Q4	$2.25M	Sell	16,728 -10,468	-38%	-$1.5M	0.09%	234
2021 Q3	$3.3M	Buy	+27,196	New	+$3.43M	0.14%	165

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

U.S. Capital Wealth Advisors's DXCM Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its DexCom (DXCM) stake by 14% in Q1 2026, buying an estimated $31.3K and bringing the position to 3,657 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #903.

U.S. Capital Wealth Advisors first reported a position in DXCM in Q3 2021 and has held it in 10 quarters since. The position peaked at $3.3M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

U.S. Capital Wealth Advisors held 3,657 shares of DexCom worth $230K as of Q1 2026.
U.S. Capital Wealth Advisors bought 449 DexCom shares in Q1 2026, an estimated $31.3K.
DexCom made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #903 holding.
U.S. Capital Wealth Advisors first reported a position in DexCom in Q3 2021 and has held it in 10 quarters since.
U.S. Capital Wealth Advisors's DexCom position peaked at $3.3M in Q3 2021.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.